Status:
TERMINATED
Smoking Cessation Support for Patients With Rheumatologic Diseases Via WhatsApp
Lead Sponsor:
Recep Tayyip Erdogan University Training and Research Hospital
Conditions:
Tobacco Use Cessation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Smoking cessation support for patients with rheumatologist diseases is an underestimated issue. In the previous prospective cohort study the investigators determined that with the brief cessation inte...
Detailed Description
In this randomized controlled study, the sample will be randomly divided to 2 arms. In one arm, usual care arm, smoker patients with rheumatologist diseases will be implemented brief smoking cessation...
Eligibility Criteria
Inclusion
- Patients applying to the rheumatology outpatient clinic
- Those aged 18 and over
- Those who are active smokers
- Those diagnosed with inflammatory rheumatic disease
- Those who gave informed written consent to participate in the study
Exclusion
- Those with active psychiatric disease diagnoses such as psychosis, major depression, schizophrenia among their current diagnoses
- Those with cognitive dysfunction
Key Trial Info
Start Date :
November 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06219551
Start Date
November 10 2023
End Date
June 30 2025
Last Update
July 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Recep Tayyip Erdoğan University, Training and Research Hospital
Rize, Turkey (Türkiye)